Stay updated with breaking news from Formerly Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
IIT Mandi is seeking applications for its multidisciplinary research event, Anusandhan 2.0, which includes an innovation fair. Researchers and scholars are encouraged to submit their abstracts or full-length papers by June 5, 2024.
Formerly Professor of Food and Beverage and Service Operations Management at EHL, Ian Scarth has a background in strategic development and leadership within the hotel and hospitality sectors. In this article he gives his views on the culture of fear and bullying the hospitality industry has gained a reputation for. He aims to shed light on our sector which is struggling with the contradiction between its core purpose of offering hospitality and the often-highlighted bullying, we have not yet eliminated from parts of our industry.
Srinagar: An online workshop on research methodology concluded at the University of Kashmir on Saturday. The five-day workshop was organised by the varsity’s Shaikh-ul Aalam Centre for Multidisciplinary Studies (SACMS) in collaboration with Ibn Arabi Society Kashmir to help young scholars of Humanities and Social Sciences disciplines to enhance their research skills and broaden their perspectives on research. Chairman SACMS Prof G
Formerly Professor of Food and Beverage and Service Operations Management at EHL, Ian Scarth has a background in strategic development and leadership within the hotel and hospitality sectors. In this article he gives his views on what it means to be a purpose-driven organisation.
WTO versus Humankind? Bharat Jhunjhunwala In the main two vaccines are available to us today—Covishield developed by AstraZeneca and produced under its license by Serum Institute of India; and Covaxin developed by Bharat Biotech. Serum Institute has to pay one-half of the sale price to AstraZeneca as royalty; or it has to pay Rs 75 as royalty if it sells Covishield to the Central Government at Rs 150. Serum Institute says that it is not economic for it to produce Covishield in the balance Rs 75. For this reason, they have offered to sell Covishield only at Rs 300 to the States and at a high...